In what could be a miracle improving and saving thousands of lives across the globe, Russia's mRNA-based vaccine Enteromix has displayed 100% efficacy and safety in clinical trials. This could be a ...

MIAMI LAKES, Fla., September 10, 2025--(BUSINESS WIRE)--Segal Trials announced its participation as a clinical research site in the pivotal studies that supported the U.S. Food and Drug Administration ...

Russian scientists have unveiled a potential game-changer in cancer care: the Enteromix vaccine, designed to shrink tumours, train the immune system to fight cancer, and avoid the harsh side effects ...

Valerie P. Hans is a member of the Board of Advisors of the Civil Justice Research Initiative. Her research on juries has been funded by the National Science Foundation, National Institute of Justice, ...

"We aspire to create the next great enduring biopharma company," said Josh Bilenker, M.D., Treeline’s Co-Founder and CEO. "Our funding mandate has allowed us to recruit proven scientists, rigorously ...

Aug. 30 (UPI) --Three former Memphis police officers convicted in the beating death of Tyre Nichols in 2023 will have new federal trials, a judge ruled. In October 2024, Tadarrius Bean, Demetrius ...

A federal judge in Tennessee ordered new trials Thursday for three former Memphis police officers who were convicted of felony counts in the beating death of Tyre Nichols after a 2023 traffic stop. A ...

Please provide your email address to receive an email when new articles are posted on . Noninferiority trials test whether a new treatment is not less efficacious than an already approved therapy.

Chad Thesen is a passionate fan of anime, video games, series, and films (Both animated and live-action). Many years of experience have left him with a deep knowledge of these mediums' intricacies and ...

An experimental weight-loss medication was shown to help people lose nearly 25% of their body weight in early-stage 1a/2b trials. The drug, amycretin — developed by Novo Nordisk — works by replicating ...

Clinical trials to explore the use of universal artificial blood are underway in Japan after initial volunteer doses began in March. The research, led by Professor Hiromi Sakai's laboratory, plans to ...